Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


18.02.2019

3 Alzheimers Dement
1 Am J Geriatr Psychiatry
4 Brain
6 J Alzheimers Dis
1 J Am Geriatr Soc
2 J Biol Chem
1 J Clin Psychiatry
1 J Neural Transm (Vienna)
2 Nat Neurosci
1 Nat Rev Neurosci
1 Neurobiol Aging
1 Neurobiol Dis
1 Neurochem Res
1 Neurology
1 Neuroreport
1 Neuroscience
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement


  1. Erratum to "Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies" [Alzheimer's & Dementia 2018;14:707-22.].
    Alzheimers Dement. 2019;15:319.
    PubMed     Text format    


  2. Erratum to "Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults" [Alzheimer's & Dementia 2018;14:1640-50.].
    Alzheimers Dement. 2019;15:319.
    PubMed     Text format    

  3. ROGALSKI EJ, Sridhar J, Martersteck A, Rader B, et al
    Clinical and cortical decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 11. pii: S1552-5260(18)33620.
    PubMed     Text format     Abstract available


    Am J Geriatr Psychiatry

  4. PRASAD KM
    Delusions in Alzheimer Disease: What Researchers Should Not Forget.
    Am J Geriatr Psychiatry. 2019 Jan 9. pii: S1064-7481(19)30008.
    PubMed     Text format    


    Brain

  5. GORDON BA, Blazey TM, Christensen J, Dincer A, et al
    Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Brain. 2019 Feb 11. pii: 5315649. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. SULTZER DL
    Cognitive ageing and Alzheimer's disease: the cholinergic system redux.
    Brain. 2018;141:626-628.
    PubMed     Text format    

  7. FRANZMEIER N, Rubinski A, Neitzel J, Kim Y, et al
    Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.
    Brain. 2019 Feb 15. pii: 5321130. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. YAMAZAKI Y, Shinohara M, Shinohara M, Yamazaki A, et al
    Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.
    Brain. 2019 Feb 15. pii: 5321132. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  9. MANSOUR Y, Blackburn K, Gonzalez-Gonzalez LO, Calderon-Garciduenas L, et al
    Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution.
    J Alzheimers Dis. 2019 Feb 2. pii: JAD181186. doi: 10.3233/JAD-181186.
    PubMed     Text format     Abstract available

  10. MANNICHE CS, Hejl AM, Hasselbalch SG, Simonsen AH, et al
    Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    J Alzheimers Dis. 2019 Feb 7. pii: JAD180816. doi: 10.3233/JAD-180816.
    PubMed     Text format     Abstract available

  11. ZHANG X, Lao K, Qiu Z, Rahman MS, et al
    Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 1. pii: JAD181084. doi: 10.3233/JAD-181084.
    PubMed     Text format     Abstract available

  12. TAKAMATSU Y, Ho G, Waragai M, Wada R, et al
    Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
    J Alzheimers Dis. 2019 Feb 6. pii: JAD180986. doi: 10.3233/JAD-180986.
    PubMed     Text format     Abstract available

  13. LI L, Ismael S, Nasoohi S, Sakata K, et al
    Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Feb 6. pii: JAD180814. doi: 10.3233/JAD-180814.
    PubMed     Text format     Abstract available

  14. GROSSBERG GT, Tong G, Burke AD, Tariot PN, et al
    Present Algorithms and Future Treatments for Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 7. pii: JAD180903. doi: 10.3233/JAD-180903.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  15. ZAROWITZ BJ, Tisdale JE
    Navigating the Minefield of QTc Interval-Prolonging Therapy in Nursing Facility Residents.
    J Am Geriatr Soc. 2019 Feb 12. doi: 10.1111/jgs.15810.
    PubMed     Text format     Abstract available


    J Biol Chem

  16. GODOY MA, Saraiva LM, Carvalho LRP, Vasconcelos-Dos-Santos A, et al
    Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-beta oligomers.
    J Biol Chem. 2017 Dec 28. pii: M117.807180. doi: 10.1074/jbc.M117.807180.
    PubMed     Text format     Abstract available

  17. TANG TC, Kienlen-Campard P, Hu Y, Perrin F, et al
    Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and gamma-secretase processing of the C99 peptide.
    J Biol Chem. 2019 Feb 12. pii: RA118.006061. doi: 10.1074/jbc.RA118.006061.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  18. RUTHIRAKUHAN M, Lanctot KL, Vieira D, Herrmann N, et al
    Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  19. SANTOS JRF, Bauer C, Schuchhardt J, Wedekind D, et al
    Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.
    J Neural Transm (Vienna). 2019 Feb 14. pii: 10.1007/s00702-019-01982.
    PubMed     Text format     Abstract available


    Nat Neurosci

  20. FANG EF, Hou Y, Palikaras K, Adriaanse BA, et al
    Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
    Nat Neurosci. 2019 Feb 11. pii: 10.1038/s41593-018-0332.
    PubMed     Text format     Abstract available

  21. CRUZ HERNANDEZ JC, Bracko O, Kersbergen CJ, Muse V, et al
    Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer's disease mouse models.
    Nat Neurosci. 2019 Feb 11. pii: 10.1038/s41593-018-0329.
    PubMed     Text format     Abstract available


    Nat Rev Neurosci

  22. BUTTERFIELD DA, Halliwell B
    Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.
    Nat Rev Neurosci. 2019 Feb 8. pii: 10.1038/s41583-019-0132.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  23. PLAGMAN A, Hoscheidt S, McLimans KE, Klinedinst B, et al
    Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance.
    Neurobiol Aging. 2019;76:201-207.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  24. SHARMA N, Tramutola A, Lanzillotta C, Arena A, et al
    Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
    Neurobiol Dis. 2019;125:176-189.
    PubMed     Text format     Abstract available


    Neurochem Res

  25. ZHOU J, Yu W, Zhang M, Tian X, et al
    Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Neurochem Res. 2019 Feb 12. pii: 10.1007/s11064-019-02748.
    PubMed     Text format     Abstract available


    Neurology

  26. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    PubMed     Text format     Abstract available


    Neuroreport

  27. SONG C, Li M, Xu L, Shen Y, et al
    Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model.
    Neuroreport. 2018;29:1517-1524.
    PubMed     Text format     Abstract available


    Neuroscience

  28. COELHO BP, Gaelzer MM, Dos Santos Petry F, Hoppe JB, et al
    Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.
    Neuroscience. 2019 Feb 13. pii: S0306-4522(19)30105.
    PubMed     Text format     Abstract available


    PLoS One

  29. MARINO S, Xu J, Zhao Y, Zhou N, et al
    Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies.
    PLoS One. 2018;13:e0202674.
    PubMed     Text format     Abstract available

  30. MOORE PJ, Lyons TJ, Gallacher J
    Random forest prediction of Alzheimer's disease using pairwise selection from time series data.
    PLoS One. 2019;14:e0211558.
    PubMed     Text format     Abstract available

  31. BEGIC E, Hadzidedic S, Kulaglic A, Ramic-Brkic B, et al
    SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    PLoS One. 2019;14:e0212261.
    PubMed     Text format     Abstract available

  32. WEINSTEIN G, Davis-Plourde KL, Conner S, Himali JJ, et al
    Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.
    PLoS One. 2019;14:e0212293.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  33. WALTI MA, Steiner J, Meng F, Chung HS, et al
    Probing the mechanism of inhibition of amyloid-beta(1-42)-induced neurotoxicity by the chaperonin GroEL.
    Proc Natl Acad Sci U S A. 2018;115:E11924-E11932.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: